CN102114058A - Production method of bee pollen tablet for treating fatty liver - Google Patents

Production method of bee pollen tablet for treating fatty liver Download PDF

Info

Publication number
CN102114058A
CN102114058A CN2010106074000A CN201010607400A CN102114058A CN 102114058 A CN102114058 A CN 102114058A CN 2010106074000 A CN2010106074000 A CN 2010106074000A CN 201010607400 A CN201010607400 A CN 201010607400A CN 102114058 A CN102114058 A CN 102114058A
Authority
CN
China
Prior art keywords
bee pollen
fatty liver
production method
treatment
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2010106074000A
Other languages
Chinese (zh)
Other versions
CN102114058B (en
Inventor
周斌
叶满红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010106074000A priority Critical patent/CN102114058B/en
Publication of CN102114058A publication Critical patent/CN102114058A/en
Application granted granted Critical
Publication of CN102114058B publication Critical patent/CN102114058B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a production method of a bee pollen tablet for treating fatty liver, relating to production technologies of product tablets. The production method comprises the following steps of: performing air stream pulverization and wall breaking on impurities-removed bee pollen; soaking in water at normal pressure and temperature; performing ultrasonic treatment; centrifuging by a refrigerated centrifuge with the rotation speed of 8000-10000rpm, taking supernatant; separating the supernatant at the ambient temperature of -5 to 5 DEG C by a molecular sieve of below 2800D to obtain water-soluble bee pollen of which the molecular weight is smaller than 2800D; performing vacuum freeze drying on the water-soluble bee pollen of which the molecular weight is smaller than 2800D to form lybee pollen lyophilized powder with the moisture content below 4%; and mixing the lyophilized powder of bee pollen with water soluble starch and tabletting. According to the production method provided by the invention, the effective components in the bee pollen are extracted by water firstly and then prepared into lyophilized powder, thus being conductive to the subsequent tabletting processing, the tablet is convenient to take, the product activity is kept, and the medicament is not liable to oxidative deterioration and has a good absorption effect and rehydration.

Description

The production method that is used for the treatment of the bee pollen tablet of fatty liver
Technical field
The present invention relates to product tablet production technology, particularly treat the bee pollen tablets agent and process for producing same of fatty liver.
Background technology
Tablet grows up on the pill basis, created 19th-century forties, to 19 end of the centurys along with compression machinery is updated, tablet applications has obtained developing rapidly.In recent ten years, there is large development tablet manufacturing technology and plant equipment aspect, as boiling granulating, direct compression of full-powder, half film coating etc.The research of Chinese medicinal tablet and production start from the fifties in last century, and along with the comprehensive study of Chemistry for Chinese Traditional Medicine, pharmacology, preparation and clinical several respects, kind, the quantity of Chinese medicinal tablet constantly increase, and Technology is improved day by day, and the quality of tablet improves gradually.Chinese medicinal tablet on type except that general compressed tablet, coated tablet, also have microencapsule tablet, buccal tablet, external sheet and effervescent tablet etc.Find out a cover gradually at the tablet manufacturing process aspect and be applicable to the process conditions that Chinese medicinal tablet is produced, as preparation to fatty oil and volatile oil tablet, how to improve Chinese medicinal tablet hardness, improve disintegration, tablet coating etc. and accumulate experience gradually, quality is improved constantly.In a word, at present tablet become wide in variety, output is big, purposes is wide, use and store and transport conveniently, one of steady quality dosage form, tablet all accounts for more than 1/3 in the preparation that the pharmacopeia of China and other many countries is recorded, visible use wide.
Fatty liver is meant the pathological changes of fatty overheap in the hepatocyte that causes owing to a variety of causes, and the positive serious threat compatriots' of fatty liver disease health becomes the second largest hepatopathy that is only second to viral hepatitis, has been acknowledged as the common cause of disguised liver cirrhosis.Fatty liver is a kind of common clinical picture, but not a kind of independently disease.The lighter is asymptomatic in its clinical manifestation, weight person's state of an illness ferociousness.Generally speaking, fatty liver belongs to the reversibility disease, and early diagnosis and treatment in time often can recover normal.The formation of fatty liver generally is because the decomposition and the anabolism disequilibrium of fat in the liver or transport the generation obstacle, fat will be in hepatocyte excess accumulation, when fat content increases to more than 30%, then be called fatty liver.Fatty liver does not cause the etiopathogenesis difference of fatty liver on an equal basis by self voxel matter difference, dietary habit, generally can be divided into obesity, cross the feeding habits fatty liver, fatty liver after the hepatitis, alcoholic fatty liver, the deficiency disease fatty liver, the medicine fatty liver, diabetic fatty liver, the latent source property fatty liver of gestational fatty liver and unknown cause etc.Fatty liver is divided into slight fatty liver, moderate fatty liver and severe fatty liver again by the light and heavy degree difference.Slight fatty liver has become modern's common problem, and the best period that slight fatty liver is the treatment fatty liver takes place.The treatment of current fatty liver is still removing the cause of disease, Cure the Primary Disease and adhere to that the reasonable diet system is main, and medicine only plays the auxiliary treatment effect.So, the research of this disease has been become the common focus and the difficult point of domestic and international research.Up to the present, Western medicine does not still have lipotropic active drug, and for well, wherein Radix Polygoni Multiflori and Fructus Crataegi are best with the Chinese medicine long-time conditioning.
Bee pollen is angiospermous pollen, and China utilizes and one of edible bee pollen country the earliest in the world.The aboundresources of China's bee pollen, but waste is serious.
The research of China's bee pollen at present is in the leading level in the world; external research also is in the primary research stages such as analysis of nutritional labeling; and a series of difficult problems such as China has solved well that bee pollen is fresh-keeping, breaking cellular wall and production; realized large-scale production; and improved alimentation rate behind the edible bee pollen greatly, for bee pollen industry leading position in the world provides powerful guarantee.However external pollen product is but more extensive on using than China, and Sweden is applied to beauty treatment with pollen food, and Japan is used as nutriment with pollen food, and France is with the function food of pollen as the growth encourage childhood development.By comparison, though the developmental research of China's bee pollen has been carried out the more than ten years, a large amount of bee pollen products has appearred, but the comprehensive processing and utilization level is also not high, the product category of existing bee pollen is single on the market, and quality is uneven, and the degree of intensive processing is not high yet, exported product is rare especially, and the resource of valuable bee pollen is not well utilized.
Summary of the invention
The object of the invention be to invent a kind of be beneficial to long preservation, and can effectively keep the production method of its active bee pollen treatment fatty liver tablet.
The present invention includes following steps:
1) bee pollen with remove impurity is immersed in the normal pressure and temperature water after the comminution by gas stream broken wall treatment, after ultrasonic Treatment, through rotating speed is 8000~10000 refrigerated centrifuger centrifugal treating of changeing, get supernatant, again with supernatant under-5~5 ℃ ambient temperature, cross the following molecular sieve of 2800D, isolate the bee pollen hydrotrope of molecular weight less than 2800D;
2) with molecular weight less than the bee pollen hydrotrope of 2800D after lyophilisation, obtain water content and be lower than 4% Herba leucadis ciliatae lyophilized powder;
3) with described Herba leucadis ciliatae lyophilized powder and water soluble starch mixing film-making.
The present invention makes lyophilized powder earlier after active ingredient water is carried in the bee pollen, be beneficial to the processing of follow-up film-making, keeps the product activity, and also have following products characteristics: packing dosage is accurate.Conveniently take; Reservation function material activity; Medicine is difficult for oxidation deterioration; Good absorbing effect; Rehydration is good; Be fit to long-distance transport, long preservation and use.
In addition, the frequency of the classification motor of comminution by gas stream broken wall treatment is 55~60Hz in the step 1) of the present invention, and bleed pressure is 0.7~1.0MPa.
The described ultrasonic treatment time of described step 1) is 10~20 minutes.
Described step 2) during lyophilisation, temperature of charge is-40 ℃~70 ℃ when sublimation drying and desorbing, and vacuum condition is 3~7Pa.
During film-making, the mass ratio that feeds intake when lyophilized powder and water soluble starch mix is 1 ︰ 0.1~10.
In the described step 3), also can sneak into lecithin and microcrystalline Cellulose PH102 film-making, the mass ratio that feeds intake of described lyophilized powder, lecithin and microcrystalline Cellulose PH102 is 1 ︰, 0.1~10 ︰ 0.1~10.
The specific embodiment
One, the lyophilized powder of preparation treatment fatty liver bee pollen water extract:
1, go-on-go bee pollen: remove impurity in the bee pollen at normal temperatures.
2, breaking cellular wall: is 55~60Hz with the bee pollen of remove impurity in the frequency of classification motor, broken wall treatment under bleed pressure 0.7~1.0MPa.
3, soak supersound process: the bee pollen after the broken wall treatment is immersed in the normal pressure and temperature water, with ultrasonic Treatment 10~20 minutes.
4, remove impurity: it is centrifugal 8~12 minutes of 8000~10000 refrigerated centrifugers that change that the material after the supersound process is placed rotating speed, removes solid impurity, gets supernatant.
5, ultrafiltration: supernatant under-5~5 ℃ ambient temperature, is crossed the following molecular sieve of 2800D, isolate molecular weight, be the bee pollen hydrotrope that is used for the treatment of fatty liver less than 2800 the hydrotrope.
6, lyophilization: the bee pollen hydrotrope that will be used for the treatment of fatty liver is-40 ℃~70 ℃ at temperature of charge, and vacuum condition is lyophilization 30~50 hours under the condition of 3~7Pa, obtains water content and is lower than 4% lyophilized powder.
Two, tabletting:
1, prescription A:
Weight ratio when mixing by lyophilized powder and water soluble starch is 1 ︰, 0.1~10 weighing respectively.
Prescription B:
Weight ratio when mixing the PH102 mixing by lyophilized powder and lecithin, water soluble starch, microcrystalline Cellulose is 1 ︰, 0.1~10 ︰, 0.1~10 ︰, 0.1~10 weighing respectively.
2, production technology:
Mix: the prescription A or the prescription B of weighing are put into respectively in the batch mixer, build cover, open the batch mixer counter-rotating and stirred 10~20 minutes, just changeing again and stirring 5 minutes, behind the mix homogeneously, the material that mixes crossed 18 mesh sieves after, form two kinds of intermixtures, standby.
Tabletting: with two kinds of intermixtures difference tablettings.
Environmental condition is a relative humidity 45%~65% between the control tabletting, 18 ℃~26 ℃ of temperature, and it is 6~10kg/mm that tabletting hardness requires 2, sheet heavily is 0.6 gram.
Coating: syrup is with film coating pre-mix dose and 55%(percent by volume) ethanol continue to stir and became syrup in about 1 hour, cross 100 mesh sieves after, carry out coating.
Three, application and curative effect:
Certain man, 45 years old, the fatty liver symptom was: ultrasound diagnosis is the moderate fatty liver.
Take the bee pollen tablet 2-4 grain of making every day, continuously after 30-60 days, sx, ultrasound diagnosis is clearly better, and it is normal that multinomial enzyme value index is recovered.

Claims (6)

1. be used for the treatment of the production method of the bee pollen tablet of fatty liver, it is characterized in that may further comprise the steps:
1) bee pollen with remove impurity is immersed in the normal pressure and temperature water after the comminution by gas stream broken wall treatment, after ultrasonic Treatment, through rotating speed is 8000~10000 refrigerated centrifuger centrifugal treating of changeing, get supernatant, again with supernatant under-5~5 ℃ ambient temperature, cross the following molecular sieve of 2800D, isolate the bee pollen hydrotrope of molecular weight less than 2800D;
2) with molecular weight less than the bee pollen hydrotrope of 2800D after lyophilisation, obtain water content and be lower than 4% Herba leucadis ciliatae lyophilized powder;
3) with described Herba leucadis ciliatae lyophilized powder and water soluble starch mixing film-making.
2. according to the described production method that is used for the treatment of the bee pollen tablet of fatty liver of claim 1, the frequency that it is characterized in that the classification motor of comminution by gas stream broken wall treatment in the described step 1) is 55~60Hz, and bleed pressure is 0.7~1.0MPa.
3. according to the described production method that is used for the treatment of the bee pollen tablet of fatty liver of claim 1, it is characterized in that the described ultrasonic treatment time of described step 1) is 10~20 minutes.
4. according to the described production method that is used for the treatment of the bee pollen tablet of fatty liver of claim 1, it is characterized in that described step 2) during lyophilisation, temperature of charge is-40 ℃~70 ℃ when sublimation drying and desorbing, vacuum condition is 3~7Pa.
5. according to the described production method that is used for the treatment of the bee pollen tablet of fatty liver of claim 1, it is characterized in that the mass ratio that feeds intake when described lyophilized powder and water soluble starch mix is 1 ︰ 0.1~10.
6. according to the described production method that is used for the treatment of the bee pollen tablet of fatty liver of claim 1, it is characterized in that in the described step 3), sneak into lecithin and microcrystalline Cellulose PH102 film-making, the mass ratio that feeds intake of described lyophilized powder, lecithin and microcrystalline Cellulose PH102 is 1 ︰, 0.1~10 ︰ 0.1~10.
CN2010106074000A 2010-12-28 2010-12-28 Production method of bee pollen tablet for treating fatty liver Expired - Fee Related CN102114058B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010106074000A CN102114058B (en) 2010-12-28 2010-12-28 Production method of bee pollen tablet for treating fatty liver

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010106074000A CN102114058B (en) 2010-12-28 2010-12-28 Production method of bee pollen tablet for treating fatty liver

Publications (2)

Publication Number Publication Date
CN102114058A true CN102114058A (en) 2011-07-06
CN102114058B CN102114058B (en) 2012-06-27

Family

ID=44213058

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010106074000A Expired - Fee Related CN102114058B (en) 2010-12-28 2010-12-28 Production method of bee pollen tablet for treating fatty liver

Country Status (1)

Country Link
CN (1) CN102114058B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697038A (en) * 2012-05-29 2012-10-03 宁夏农林科学院 Medlar bee pollen tablet
CN102940653A (en) * 2012-11-30 2013-02-27 扬州大学 Bee pollen water extract buccal tablet for preventing and treating alcoholic fatty liver

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1709140A (en) * 2005-07-08 2005-12-21 周云川 Composite melissa powder and its production process
CN101537048A (en) * 2009-04-14 2009-09-23 文永盛 Application of buckwheat and bee pollen in preparing drugs and method for preparing capsules and tablets thereby
CN101756088A (en) * 2010-02-05 2010-06-30 王平 Preparation method of novel pine pollen preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1709140A (en) * 2005-07-08 2005-12-21 周云川 Composite melissa powder and its production process
CN101537048A (en) * 2009-04-14 2009-09-23 文永盛 Application of buckwheat and bee pollen in preparing drugs and method for preparing capsules and tablets thereby
CN101756088A (en) * 2010-02-05 2010-06-30 王平 Preparation method of novel pine pollen preparation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
《中国养蜂》 19981130 潘建国等 蜂花粉中过氧化氢酶活性测定新方法的探讨 第49卷, 第06期 *
《中国蜂业》 20060228 陈崇羔等 不同破壁方法对蜂花粉超氧化物歧化酶活性的影响 , 第02期 2 *
《浙江医学》 19890131 庄月明等 蜂花粉的护肝作用 , 第01期 2 *
《蜜蜂杂志》 19890131 匡邦郁等 蜂花粉不同干燥方法试验 , 第01期 2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697038A (en) * 2012-05-29 2012-10-03 宁夏农林科学院 Medlar bee pollen tablet
CN102940653A (en) * 2012-11-30 2013-02-27 扬州大学 Bee pollen water extract buccal tablet for preventing and treating alcoholic fatty liver

Also Published As

Publication number Publication date
CN102114058B (en) 2012-06-27

Similar Documents

Publication Publication Date Title
CN103494007B (en) A kind of anti diar rhea pig starter feed and preparation method thereof
CN102114053B (en) Method for producing pine pollen tablets for treating fatty liver
CN101536780A (en) Glue tonifying food and health care food
CN1656913A (en) Instant oats coffee and its preparation method
CN106336445B (en) The preparation method and application of compound 20 (R) ginseng sapoglycoside Rg 3
CN105053802A (en) Highland barley instant powder and preparation method thereof
CN107281218B (en) High-absorption composite calcium supplement preparation and preparation method thereof
WO2020173172A1 (en) Composition of slimming tablet and preparation method therefor
CN102114058B (en) Production method of bee pollen tablet for treating fatty liver
CN105595143A (en) Solid arecoline beverage and preparation method thereof
CN1562204A (en) Technique of extracting acitve ingredient from roots, stems and leaves from artichoke and application
CN106866691A (en) A kind of method for extracting sesamin
CN103919020A (en) Preparation method for hard wheat grain based pumpkin whole-grain steamed buns
CN103583657A (en) Herba portulacae nutrition health care bread
CN102114052B (en) Production method of pine pollen soft capsule for treating fatty liver
CN1692803A (en) Method for preparing cooked-rice made of buck wheat
CN105031404A (en) Traditional Chinese and western medicinal compound preparation for reducing weight and lowering lipid
CN105249441A (en) Folium mori health care product for reducing blood glucose and preparation method thereof
CN105147899A (en) Preparation for protecting stomach, protecting liver and dissipating effects of alcohol and application of preparation
CN104783177A (en) Maca preparation
CN102114049A (en) Method for producing bee pollen tablets for treating premature ovarian failure of women
CN102114054A (en) Production method of pine pollen tablets for treating premature ovarian failure of women
CN102114048B (en) Production method of bee pollen soft capsules for treating fatty liver
CN110300594B (en) Pharmaceutical composition for controlling blood sugar
CN105053996A (en) Nutritional tablet for enhancing immunity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: 225800 Jiangsu city of Yangzhou province Baoying County West Industrial Zone Chuangye Road No. 26

Patentee after: Zhou Bin

Patentee after: Ye Manhong

Address before: 225001 Jiangsu City, Yangzhou Old City Lane seven 18-3

Patentee before: Zhou Bin

Patentee before: Ye Manhong

CP02 Change in the address of a patent holder

Address after: No. 8, Dashan Industrial Park, Gao Hong Kong, Taizhou, Jiangsu

Co-patentee after: Ye Manhong

Patentee after: Zhou Bin

Address before: 225800 Jiangsu city of Yangzhou province Baoying County West Industrial Zone Chuangye Road No. 26

Co-patentee before: Ye Manhong

Patentee before: Zhou Bin

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120627

Termination date: 20171228

CF01 Termination of patent right due to non-payment of annual fee